http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108815171-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108815171-B |
| titleOfInvention | Application of 25-hydroxycholesterol in preparation of medicine for treating or preventing myocardial infarction |
| abstract | The invention discovers that 25-hydroxycholesterol has the activities of inhibiting myocardial infarction and protecting myocardial cells through research, and further provides application of the 25-hydroxycholesterol in preparing medicaments for treating or preventing myocardial infarction, or protecting the myocardial cells of the myocardial infarction and preventing heart failure after the myocardial infarction, and a method for treating or preventing the myocardial infarction, the myocardial cells of the myocardial infarction and the heart failure after the myocardial infarction by using the 25-hydroxycholesterol. The application of the invention has the advantages of high safety and less toxic and side effects. |
| priorityDate | 2018-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.